Evidence map›Paper›PMID 28105078›Full record

ReviewEcancermedicalscience2016

The current situation for gastric cancer in Chile.

Christian Caglevic, Shirley Silva, Mauricio Mahave, Christian Rolfo, Jorge Gallardo

Abstract readReview
In one paragraph

Review in Ecancermedicalscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christian CaglevicCancer Drug Research Unit, Fundación Arturo López Pérez, Santiago, Chile; Instituto Oncológico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Shirley SilvaRadiation Oncology, University of Valparaíso, Valparaíso, Chile; Instituto Oncológico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Mauricio MahaveMedical Oncology Service, Fundación Arturo López Pérez, Santiago, Chile; Instituto Oncológico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Christian RolfoEarly Drug Development Unit - Phase I, University Hospital of Antwerp, Antwerp, Belgium; Instituto Oncológico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Jorge GallardoFundación Chilena Desarrollo Oncología, SLAGO (Latin American Symposium on Oncological Gastroenterology), Santiago, Chile.; Instituto Oncológico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer is a neoplasm with a high incidence and mortality rate in Chile where more than 3000 people die every year from this type of cancer. This study shows the clinical and epidemiological considerations of this disease, information about translational research on this pathology in Chile, the contribution of Chilean doctors to the development of gastric cancer management awareness and the general situation of gastric cancer in Chile.

Indexed as

Chileepidemiologygastric cancergastric cancer treatment in Chileinvestigation

Identifiers

PMID28105078
PMCPMC5221643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.